Skip to main content
. Author manuscript; available in PMC: 2022 Jul 4.
Published in final edited form as: Rev Recent Clin Trials. 2017;12(2):111–123. doi: 10.2174/1574887112666170321121250

Fig. (1).

Fig. (1).

The initial steps in the clinical development process for a new therapeutic provides a bridge between the basic science, originally suggesting that a disease-causing pathway could be targeted therapeutically, and the definitive studies that convince regulatory agencies that the therapy can beneficially influence outcomes in a patient population.